Literature DB >> 31715030

Glucocorticoid and β-adrenergic regulation of hippocampal dendritic spines.

Sylvie L Lesuis1,2, Wendy Timmermans1, Paul J Lucassen1, Casper C Hoogenraad3, Harm J Krugers1.   

Abstract

Glucocorticoid hormones are particularly potent with respect to enhancing memory formation. Notably, this occurs in close synergy with arousal (i.e., when norepinephrine levels are enhanced). In the present study, we examined whether glucocorticoid and norepinephrine hormones regulate the number of spines in hippocampal primary neurons. We report that brief administration of corticosterone or the β-adrenergic receptor agonist isoproterenol alone increases spine number. This effect becomes particularly prominent when corticosterone and isoproterenol are administered together. In parallel, corticosterone and isoproterenol alone increased the amplitude of miniature excitatory postsynaptic currents, an effect that is not amplified when both hormones are administered together. The effects of co-application of corticosterone and isoproterenol on spines could be prevented by blocking the glucocorticoid receptor antagonist RU486. Taken together, both corticosterone and β-adrenergic receptor activation increase spine number, and they exert additive effects on spine number for which activation of glucocorticoid receptors is permissive.
© 2019 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.

Entities:  

Keywords:  corticosterone; memory; norepinephrine; plasticity; spines; synapses

Mesh:

Substances:

Year:  2019        PMID: 31715030      PMCID: PMC7003927          DOI: 10.1111/jne.12811

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


INTRODUCTION

During stress exposure, norepinephrine (NE) is rapidly released by presynaptic terminals from neurons that originate from the locus coeruleus. Consequently, NE is released in brain regions that are key in memory formation such as the hippocampus.1 More slowly after stress exposure, the hypothalamus‐pituitary‐adrenal axis is activated, which increases circulating levels of glucocorticoids (GCs). As a result of their lipophilic nature, GCs readily enter the brain where they bind to high affinity mineralocorticoid receptors (MRs) and lower affinity glucocorticoid receptors (GRs), which are both present at high levels in the hippocampal formation.1, 2 Activation of MRs and GRs regulates various cellular functions via genomic and non‐genomic actions.3 In this way, stress promotes behavioural adaptation to stressful experiences.2, 4 By enhancing habitual learning strategies, glucocorticoid hormones modulate response selection after stress exposure via MRs.5, 6 Via GRs, glucocorticoid hormones enhance memory consolidation.7, 8, 9, 10 At the cellular level, GC effects involve rapid changes in glutamatergic synaptic transmission, including enhanced neurotransmitter release and alterations in AMPA and NMDA receptor mobility.11, 12, 13, 14 More slowly, corticosterone enhances glutamatergic (AMPA and NMDA receptor‐mediated) synaptic transmission, which underlies enhanced memory formation.11, 15, 16, 17, 18, 19, 20 In addition, various lines of evidence indicate that glucocorticoids also enhance spine formation, which are critical for learning and memory.21, 22, 23, 24, 25, 26, 27, 28 Importantly, glucocorticoids are particularly potent with respect to enhancing memory formation when NE levels, acting via β‐adrenergic receptors, are also enhanced, both in humans and rodents.29, 30 At the cellular level, GCs and NE in concert regulate synaptic transmission by enhancing the frequency of miniature excitatory postsynaptic currents (mEPSCs) and synaptic plasticity.31, 32, 33 Whether and how GCs and NE interact to also regulate the number of spines remains elusive. The present study therefore examined whether GCs and NE regulate the number of spines, both alone, or in an additive mode.

MATERIALS AND METHODS

Rat hippocampal primary cultures

Primary hippocampal cultures were prepared from Wistar rat brains at embryonic day 18 ± 1, as described previously.16, 17, 34 Briefly, hippocampi were dissected and homogenised, and cells were plated on 12 mm coverslips coated with poly‐d‐lysine (0.5 mg mL‐1) at a density of 75 000 neurons/coverslip. Hippocampal cultures were grown in neurobasal medium supplemented with 2% B27, 0.5 mmol L‐1 GlutaMax (ThermoFisher, Waltham, MA, USA), penicillin/streptomycin, 5% foetal bovine serum (FBS) (plating medium) for the first day; from the second day onwards, half of the medium was changed once a week with culturing medium (plating medium without FBS), containing 5‐fluoro‐2′‐deoxyuridine (FUDR) 10 μmol L‐1 to inhibit glial growth. All reagents were obtained from Gibco Invitrogen (Carlsbad, CA, USA), except FUDR (Sigma). All experiments were carried out with permission of the local Animal Committee of the University of Amsterdam.

Lipofectamine transfection with GFP

Days in vitro (DIV) 13‐17 hippocampal neurons were transfected using Lipofectamine2000 (Invitrogen, Carlsbad, CA, USA) and a total of 1 μg of plasmids, containing a 1:1 ratio of green fluorescent protein (pGW1‐GFP) and empty vector (pGW1). Lipofectamine‐GFP‐empty vector mixture was incubated for 30 minutes before being added to the neuronal cultures for 45 minutes at 37°C and 5% CO2. Next, the neurons were washed and transferred back to their original medium at 37°C, 5% CO2 for 24 hours.

Experimental design and hormone treatment

After transfection, DIV 14‐18 hippocampal neurons were subjected to either: (a) vehicle (veh) (EtOH, concentration <0.01%), (b) 100 nmol L‐1 corticosterone (CORT) (Sigma); (c) 1 μmol L‐1 isoproterenol (ISO), an NE agonist (Sigma); or (d) both 100 nmol L‐1 CORT and 1 μmol L‐1 isoproterenol. Neurons were then incubated at 37°C, 5% CO2 for either 20 minutes, followed by direct fixation (Experiment 1), or for 20 minutes, after which they were placed back in incubation medium for a remaining 160 minutes (Experiment 2), or for 180 minutes (Experiment 5). In addition, neurons were exposed to the GR antagonist RU486 (500 nmol L‐1, Sigma) for 1 hour prior to the aforementioned treatments with either CORT, or CORT and ISO together (Experiment 3). Colocalisation between the spine heads and the presynaptic marker Bassoon was assessed (Experiment 4). After incubation, neurons were fixed for 15 minutes with 4% formaldehyde/4% sucrose in 0.1 mol L‐1 phosphate‐buffered saline, and washed three times in phosphate buffer (PB) with intervals of 10 minutes. For Experiment 6, neurons underwent a hormone treatment similar to that employed in Experiment 2, and mEPSCs were recorded after 160 minutes.

Immunohistochemistry

Neurons were incubated in GDB + Triton X‐100 buffer (0.2% bovine serum albumin, 0.8 mol L‐1 NaCl, 30 mmol L‐1 phosphate buffer, 0.6% Triton X‐100, pH 7.4) containing the primary antibody against the presynaptic protein bassoon (bassoon; Enzo Diagnostics, Farmingdale, NY, USA; dilution 1:200; 1 mg mL‐1) for 2 hours at room temperature. After three washes in PB with 10‐minute intervals in between, neurons were incubated with GDB + Triton X‐100 buffer containing the secondary antibody Alexa Fluor goat‐anti‐mouse mA568 (Invitrogen; dilution 1:400; 2 mg mL‐1) for 2 hours at room temperature. Neurons were again washed three times in PB with 10‐minute intervals before mounting using Vectashield mounting medium (Vector Laboratories, Inc., Burlingame, CA, USA).

Image acquisition

Confocal images were obtained using an LSM 510 microscope (Carl Zeiss, Oberkochen, Germany) with a 63× oil objective with acquisition settings at 1024 × 1024 pixels resolution. lsm software was used to generate Z series projections of approximately six to 10 images, each averaged four times and taken at a fixed 0.4 μm depth interval. For all images, the confocal settings were kept equal.

Spine density

In each condition, a minimum of three secondary dendrites of ten different GFP transfected neurons were randomly chosen for quantification. For each neurone, a minimum total amount of 120 μm of dendrite was analysed using metamorph image analysis software (Universal Imaging Corporation, Bedford Hills, NY, USA). Single dendrites were selected at random, and protrusion width and length were manually measured (Figure 1A), as well as its possible co‐localisation with bassoon. The width/length ratio of the protrusion was used to classify protrusions into filopodia or spines. If the width/length ratio exceeded 0.5, the protrusion was classified as a spine, protrusions with a ratio below 0.5 were classified as filopodia.35 In case the total length of the protrusion could not be adequately measured or its length was over 5 μm, the protrusions were excluded from analysis. An investigator who was blind to the experimental conditions carried out the morphological analyses.
Figure 1

Spine and filopodium density after 20 minutes of hormone treatment. A, Typical example of protrusion measurements. The length of the protrusion is measured from the base to the top (1,3). Maximal protrusion head width is measured from side to side, parallel to the postsynaptic density (2,4). The latter protrusion displays colocalisation with bassoon. B, Time schedule of the experiment. C, No effects on spine density were present in any of the treatments. D, No effects on filopodium density were present in any of the treatments. *P < 0.05. Data are expressed as the mean ± SEM (n = 8‐9 neurons/group). veh, vehicle; IHC, immunohistochemistry

Spine and filopodium density after 20 minutes of hormone treatment. A, Typical example of protrusion measurements. The length of the protrusion is measured from the base to the top (1,3). Maximal protrusion head width is measured from side to side, parallel to the postsynaptic density (2,4). The latter protrusion displays colocalisation with bassoon. B, Time schedule of the experiment. C, No effects on spine density were present in any of the treatments. D, No effects on filopodium density were present in any of the treatments. *P < 0.05. Data are expressed as the mean ± SEM (n = 8‐9 neurons/group). veh, vehicle; IHC, immunohistochemistry

Electrophysiology

Coverslips with cells attached were placed in a recording chamber mounted on an upright microscope (Axioskop 2FS Plus; Carl Zeiss), which were kept fully submerged with artificial cerebrospinal fluid containing (in mmol L‐1): 145 NaCl, 2.8 KCl, 1.0 MgCl2, 10 Hepes and 10 glucose (pH 7.4). Whole‐cell patch‐clamp recordings were made using an AXOPATCH 200 amplifier (Axon Instruments, Foster City, CA, USA), with electrodes from borosilicate glass (1.5 mm outer diameter; Hilgerberg, Malsfeld, Germany). The electrodes were pulled on a Suttter micropipette puller. The pipette solution contained (in mmol L‐1): 120 Cs methane sulfonate; 17.5 CsCl, 10 Hepes, 5 BAPTA, 2 Mg‐ATP, 0.5 Na‐GTP and 10 QX‐314 (pH 7.4), adjusted with CsOH; pipette resistance was between 3 and 6 MΩ. Under visual control (40× objective and 10× ocular magnification), the electrode was directed towards a neurone with positive pressure. Once sealed on the cell membrane (resistance above 1 GΩ), the membrane patch under the electrode was ruptured by gentle suction and the cell was kept at a holding potential of −70 mV. The liquid junction potential caused a shift of no more than 10 mV, which was compensated for during the mEPSC recordings. Recordings with an uncompensated series resistance of <15 MΩ and <2.5 times of the pipette resistance with a shift of <20% during the recording, were accepted for analysis. Data acquisition was performed with pclamp, version 8.2 (Molecular Devices, Sunnyvale, CA, USA) and analysed offline with mini‐analysis, version 6.0 (Synaptosoft Inc., Fort Lee, NJ, USA). mEPSCs were recorded at a holding potential of −70 mV.16, 17 Tetrodotoxin (0.25 µmol L‐1; Latoxan, Portes lès Valence, France) and bicuculline methobromide (20 µmol L‐1; Biomol, Hamburg, Germany) were added to the buffer to block action potential induced glutamate release and GABA‐A receptor‐mediated miniature inhibitory postsynaptic currents, respectively. During some recordings the non‐NMDA receptor blocker 6‐cyano‐7‐nitroquinoxaline‐2,3‐dione (10 mol L‐1; Tocris Bioscience, St Louis, MO, USA) was perfused to confirm that the mEPSCs were indeed mediated by AMPA receptors. The events were identified as mEPSCs when the rise time was faster than the decay time. mEPSCs were recorded for 3 minutes in each cell.

Statistical analysis

Statistical analysis was performed using spss, version 17.0 (SPSS Inc., Chicago, IL, USA). All data are expressed as mean ± SEM. Outliers were removed using Grubb's test. Between‐group comparisons were carried out using a one‐way ANOVA followed by a post‐hoc Sidak test. P < 0.05 was considered statistically significantly.

RESULTS

Experiment 1: Immediate (20 minutes) effects of stress hormones on dendritic spine density

To investigate the immediate effects of CORT or the β‐receptor agonist ISO on the density of spines or filopodia, primary neurons were treated with these hormones for 20 minutes, after which protrusion morphology and density were assessed (Figure 1A, B). No differences were found for total spine or filopodium density immediately after 20 minutes of treatment (spines: F 3,31 = 1.75, P = 0.18); filopodia: F 3,31 = 2.07, P = 0.12; Figure 1C‐D).

Experiment 2: Later (180 minutes) effects of brief exposure to stress hormones on dendritic spine density

Because the effects of the hormone treatment on spine density may require time to arise, we next investigated effects of 20 minutes of hormone treatment on spine density after a 3‐hour follow‐up (Figure 2A). Spine density was increased after CORT (F 3,33 = 47.71, P < 0.0001, post‐hoc: P = 0.01), ISO (P < 0.0001) and ISO + CORT (P < 0.0001) (Figure 2B). Although ISO increased spine density more than CORT alone (P = 0.0007), the combined ISO + CORT treatment increased spine density even more (P = 0.007).
Figure 2

Spine and filopodium density after 3 h with 20 minutes of hormone treatment. A, Time schedule of the experiment. B, Spine density was increased after CORT, ISO and CORT + ISO treatment compared to vehicle (veh). Co‐administration of CORT + ISO resulted in the highest spine density. C, Filopodium density was increased after ISO and CORT + ISO treatment compared to vehicle. Co‐administration of CORT + ISO resulted in the highest spine density. *P < 0.05. Data are expressed as the mean ± SEM (n = 8‐10 neurons/group). IHC, immunohistochemistry

Spine and filopodium density after 3 h with 20 minutes of hormone treatment. A, Time schedule of the experiment. B, Spine density was increased after CORT, ISO and CORT + ISO treatment compared to vehicle (veh). Co‐administration of CORT + ISO resulted in the highest spine density. C, Filopodium density was increased after ISO and CORT + ISO treatment compared to vehicle. Co‐administration of CORT + ISO resulted in the highest spine density. *P < 0.05. Data are expressed as the mean ± SEM (n = 8‐10 neurons/group). IHC, immunohistochemistry Filopodium density was not affected by CORT treatment alone (F 3,33 = 21.10, P < 0.0001, post‐hoc: P = 0.17), although it was increased by ISO (P < 0.0001) and by CORT + ISO (P < 0.0001) (Figure 2C). CORT also did not further increase the filopodium density following CORT + ISO compared to ISO treatment alone (P = 0.41).

Experiment 3: Role of GR in CORT and ISO mediated spine density

The GR antagonist RU486 was used to investigate whether the CORT and ISO mediated effects on spine and filopodium density are mediated via the GR (Figure 3A). RU486 pre‐exposure before CORT treatment did not affect spine or filopodium density (spines: F 3,34 = 15.36, P < 0.0001, veh‐CORT vs RU486CORT: P = 0.75; filopodia: F 3,35 = 5.13, P = 0.005, veh‐CORT vs RU486CORT: P = 0.66) (Figure 3B,C). Yet, pre‐exposure to RU486 completely blocked the enhancing effects of combined CORT + ISO treatment on spine (P < 0.0001) and filopodium density (P = 0.006).
Figure 3

Spine and filopodium density after pre‐treatment with glucocorticoid receptor antagonist RU486. A, Time schedule of the experiment. B, Pre‐treatment with RU486 did not affect spine density after CORT treatment. Vehicle (veh) treatment did not affect the previously observed increased in spine density after CORT + ISO compared to CORT treatment, although it did block the additional effect that CORT + ISO had on spine density. C, Pre‐treatment with RU486 decreased the filopodium density after CORT + ISO treatment. *P < 0.05. Data are expressed as the mean ± SEM (n = 8‐10 neurons/group). IHC, immunohistochemistry

Spine and filopodium density after pre‐treatment with glucocorticoid receptor antagonist RU486. A, Time schedule of the experiment. B, Pre‐treatment with RU486 did not affect spine density after CORT treatment. Vehicle (veh) treatment did not affect the previously observed increased in spine density after CORT + ISO compared to CORT treatment, although it did block the additional effect that CORT + ISO had on spine density. C, Pre‐treatment with RU486 decreased the filopodium density after CORT + ISO treatment. *P < 0.05. Data are expressed as the mean ± SEM (n = 8‐10 neurons/group). IHC, immunohistochemistry

Experiment 4: Synaptic integration of protrusions

The functional integration of protrusions was assessed by the density of colocalised protrusion heads with the presynaptic protein bassoon.36 Twenty minutes after hormone treatment, there was no difference in the density of colocalised protrusion heads with bassoon between any of the treatment groups (F 3,30 = 2.09, P = 0.12) (Figure 4A). Interestingly, 3 hours after the 20 minutes of hormone treatment, the CORT + ISO protrusions showed higher co‐localisation with bassoon than vehicle‐treated neurons (F 3,32 = 4.43, P = 0.01, post‐hoc: P = 0.007) (Figure 4B).
Figure 4

Colocalisation of protrusions with bassoon. A, 20 minutes after hormone treatment, there was no effect on the colocalisation of protrusion heads with bassoon. B, 160 minutes later, there was an increase in the protrusion heads that colocalised with bassoon after CORT + ISO treatment. *P < 0.05. Data are expressed as the mean ± SEM (n = 7‐10 neurons/group). veh, vehicle

Colocalisation of protrusions with bassoon. A, 20 minutes after hormone treatment, there was no effect on the colocalisation of protrusion heads with bassoon. B, 160 minutes later, there was an increase in the protrusion heads that colocalised with bassoon after CORT + ISO treatment. *P < 0.05. Data are expressed as the mean ± SEM (n = 7‐10 neurons/group). veh, vehicle

Experiment 5: Effects of long‐term (180 minutes) exposure to stress hormones on dendritic spine density

Because prolonged treatment with CORT may negatively affect spine number, we also investigated whether longer, 180 minutes, treatment with CORT and ISO affected spine formation (Figure 5A). Spine density was increased after ISO (F 3,36 = 6.28, P < 0.01, post‐hoc: P = 0.01) and ISO + CORT (P < 0.01) (Figure 5B). Likewise, filopodium density was affected after ISO (F 3,36 = 6.11, P<0.01, post‐hoc: P < 0.01) and ISO + CORT (P < 0.01) (Figure 5C). Three hours after the 180 minutes treatment, the CORT + ISO and ISO‐treated protrusions showed higher co‐localisation with bassoon than vehicle‐treated neurons (F 3,36 = 4.80, P = 0.01, post‐hoc: P < 0.05 and P < 0.01, respectively) (Figure 5B). We conclude that prolonged treatment with ISO + CORT or CORT alone does not negatively affect spine number, and also that ISO + CORT treatment enhances spine density.
Figure 5

Spine and filopodium density after 3 hours of hormone treatment. A, Time schedule of the experiment. B, Spine density was increased after ISO and CORT + ISO treatment compared to vehicle (veh). C, Filopodium density was increased after ISO and CORT + ISO treatment compared to vehicle. D, Colocalisation of protrusions with bassoon. There was an increase in the protrusion heads that colocalised with bassoon after ISO and CORT + ISO treatment. *P < 0.05. Data are expressed as the mean ± SEM (n = 8‐10 neurons/group). IHC, immunohistochemistry

Spine and filopodium density after 3 hours of hormone treatment. A, Time schedule of the experiment. B, Spine density was increased after ISO and CORT + ISO treatment compared to vehicle (veh). C, Filopodium density was increased after ISO and CORT + ISO treatment compared to vehicle. D, Colocalisation of protrusions with bassoon. There was an increase in the protrusion heads that colocalised with bassoon after ISO and CORT + ISO treatment. *P < 0.05. Data are expressed as the mean ± SEM (n = 8‐10 neurons/group). IHC, immunohistochemistry

Experiment 6: Functional consequences of hormone treatment

To assess the functional consequences of enhanced spine density and synaptic integration, we next measured mEPSCs of primary neurons 3 hours after 20 minutes of hormone treatment (Figure 6A). The mEPSC amplitude was increased following both CORT, ISO and CORT + ISO (F 3,59 = 4.98, P = 0.004, post‐hoc veh‐CORT: P = 0.018; veh‐ISO: P = 0.029; veh‐CORT + ISO: P = 0.04) (Figure 6B). There was no effect of any hormone treatment on the frequency (F 3,57 = 2.51, P = 0.07) (Figure 6C) or the decay time (F 3,59 = 1.78, P = 0.16) (Figure 6D) of the mEPSCs.
Figure 6

Miniature excitatory postsynaptic currents (mEPSCs) after 3 h with 20 minutes of hormone treatment. A, Time schedule of the experiment. B, mEPSC amplitude was increased after CORT, ISO and CORT + ISO treatment compared to vehicle (veh). C, mEPSC frequency was not affected by any of the treatments. D, The decay time of the mEPSCs was not affected by any of the treatments. *P < 0.05. Data are expressed as the mean ± SEM (n = 11‐24 neurons/group)

Miniature excitatory postsynaptic currents (mEPSCs) after 3 h with 20 minutes of hormone treatment. A, Time schedule of the experiment. B, mEPSC amplitude was increased after CORT, ISO and CORT + ISO treatment compared to vehicle (veh). C, mEPSC frequency was not affected by any of the treatments. D, The decay time of the mEPSCs was not affected by any of the treatments. *P < 0.05. Data are expressed as the mean ± SEM (n = 11‐24 neurons/group)

DISCUSSION

In the present study, we examined whether CORT and β‐adrenergic receptor activation, alone and in concert, regulate spine density. We report that both CORT and the β‐adrenergic receptor agonist ISO increase spine density, an effect that is increased when CORT and ISO are administered together. Interestingly, this effect of co‐application is prevented by blocking the GR with the GR antagonist RU486. These results suggest that both CORT and β‐adrenergic receptor activation increase spine density, and that they exert additive effects that require GR activation. Although CORT and ISO did increase the amplitude of mEPSCs, we did not observe an additive effect of these hormones on mEPSC amplitude. Various lines of evidence indicate that corticosteroid hormones increase (learning‐evoked) spine formation and spine stabilisation.21, 22, 23, 24, 25, 26, 27, 28 In line with these findings, we report that CORT increases hippocampal spine number in primary cultures. We further report that activation of β‐adrenergic receptors, using the β‐adrenergic receptor agonist ISO, also enhances spine number. Both effects required time, which may suggest that protein synthesis is required.31 Interestingly, combined administration of CORT and ISO further increased the number of spines, which was dependent on GR activation because the GR antagonist RU486 prevented this effect. At present, it still remains unknown why the effects of CORT on spines were not prevented by RU486. One of the possibilities is that MRs might (also) be involved in spine formation.28 At 3 hours after co‐administration, the number of spines that colocalised with the presynaptic marker bassoon was increased. To examine the possible functional consequences in more detail, mEPSCs were recorded after administration of CORT and/or ISO. Both CORT and ISO increased the amplitude of mEPSCs and enhanced synaptic potentiation. Such effects may be linked to increased trafficking and retention of synaptic AMPARs.11, 15, 16, 17, 37, 38, 39, 40 Yet, we found that, 160 minutes after combined CORT and ISO administration, mEPSC frequency and amplitude were not further increased compared to the administration of the drugs alone. These findings suggest that the increase in spine number after co‐administration of ISO and CORT leaves synaptic transmission unaffected at 3 hours. Earlier studies have shown that combined administration of ISO and CORT within minutes increases synaptic transmission by enhancing mEPSC frequency32 and long‐term potentiation.33 Although we observed increases in spine density after 3 hours but not after 20 minutes of co‐application, this is not reflected in the mEPSC amplitude. Although we observed a moderate increase in bassoon colocalisation at 3 hours after co‐administration, the proper functional integration of new spines into the network after exposure to GCs and ISO may require more time. Alternatively, the increase in spines may prepare the capacity of the network for synaptic plasticity. The formation of presynaptic boutons and the initiation of synaptogenesis, resulting in the formation of spines and their functional integration into the network, is a highly dynamic process, displaying vast ranges of changes in shape over short time.41 Thus, to investigate the stability of our observed changes and their full functional integration, it will be important to investigate in more detail the generation and retraction of spines after combined exposure over longer periods of time.21, 28 In conclusion, behavioural studies indicate that glucocorticoids and NE together promote memory retention, both in rodents29 and humans.30 The results of the present study indicate that these modulators, in an additive fashion, also regulate spine number, although, at the currently examined time points, synaptic transmission was not altered when compared to single administration . It will be important to investigate whether these effects of CORT and ISO on spine number are necessary for their effects on memory consolidation.42 Moreover, because prolonged exposure to GCs reduces spine formation,42 it will be important to understand mechanisms that underlie the transition from increased to reduced spinogenesis.
  43 in total

1.  A requirement for epigenetic modifications during noradrenergic stabilization of heterosynaptic LTP in the hippocampus.

Authors:  N J Brandwein; P V Nguyen
Journal:  Neurobiol Learn Mem       Date:  2019-03-28       Impact factor: 2.877

2.  GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking.

Authors:  Casper C Hoogenraad; Aaron D Milstein; Iryna M Ethell; Mark Henkemeyer; Morgan Sheng
Journal:  Nat Neurosci       Date:  2005-07       Impact factor: 24.884

3.  Interacting noradrenergic and corticosteroid systems shift human brain activation patterns during encoding.

Authors:  Anda H van Stegeren; Benno Roozendaal; Merel Kindt; Oliver T Wolf; Marian Joëls
Journal:  Neurobiol Learn Mem       Date:  2009-08-18       Impact factor: 2.877

4.  Beta-adrenergic receptor activation facilitates induction of a protein synthesis-dependent late phase of long-term potentiation.

Authors:  Jennifer N Gelinas; Peter V Nguyen
Journal:  J Neurosci       Date:  2005-03-30       Impact factor: 6.167

Review 5.  The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission.

Authors:  Maurizio Popoli; Zhen Yan; Bruce S McEwen; Gerard Sanacora
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

6.  Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala.

Authors:  Benno Roozendaal; Shoki Okuda; Eddy A Van der Zee; James L McGaugh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-12       Impact factor: 11.205

7.  Corticosterone enhances long-term retention in one-day-old chicks trained in a weak passive avoidance learning paradigm.

Authors:  C Sandi; S P Rose
Journal:  Brain Res       Date:  1994-05-30       Impact factor: 3.252

8.  Corticosterone induces rapid spinogenesis via synaptic glucocorticoid receptors and kinase networks in hippocampus.

Authors:  Yoshimasa Komatsuzaki; Yusuke Hatanaka; Gen Murakami; Hideo Mukai; Yasushi Hojo; Minoru Saito; Tetsuya Kimoto; Suguru Kawato
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

9.  Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals.

Authors:  S tom Dieck; L Sanmartí-Vila; K Langnaese; K Richter; S Kindler; A Soyke; H Wex; K H Smalla; U Kämpf; J T Fränzer; M Stumm; C C Garner; E D Gundelfinger
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

10.  Corticosterone rapidly increases thorns of CA3 neurons via synaptic/extranuclear glucocorticoid receptor in rat hippocampus.

Authors:  Miyuki Yoshiya; Yoshimasa Komatsuzaki; Yasushi Hojo; Muneki Ikeda; Hideo Mukai; Yusuke Hatanaka; Gen Murakami; Mitsuhiro Kawata; Tetsuya Kimoto; Suguru Kawato
Journal:  Front Neural Circuits       Date:  2013-11-27       Impact factor: 3.492

View more
  2 in total

1.  Glucocorticoid and β-adrenergic regulation of hippocampal dendritic spines.

Authors:  Sylvie L Lesuis; Wendy Timmermans; Paul J Lucassen; Casper C Hoogenraad; Harm J Krugers
Journal:  J Neuroendocrinol       Date:  2019-12-05       Impact factor: 3.627

Review 2.  An emerging role for microglia in stress-effects on memory.

Authors:  Jeniffer Sanguino-Gómez; Jacobus C Buurstede; Oihane Abiega; Carlos P Fitzsimons; Paul J Lucassen; Bart J L Eggen; Sylvie L Lesuis; Onno C Meijer; Harm J Krugers
Journal:  Eur J Neurosci       Date:  2021-05-04       Impact factor: 3.698

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.